FDA Finds High Levels of Carcinogen in Extended-Release Metformin
May 28th 2020Months after FDA said it was investigating the carcinogenic ingredient NDMA in metformin products, the agency’s testing has found elevated levels of NDMA in extended release metformin, but not in the immediate release formulation.
Pharmacy Groups Praise HHS Guidance Allowing Pharmacists to Provide COVID-19 Testing
April 9th 2020Expanding COVID-19 testing is "a critical component in our nation's efforts to reduce the number of cases, ease burdens on our over-utilized hospitals and clinics, and protect the safety of our communities," the Pharmacists for Healthier Lives coalition said.